Better U and Evernow Pair Menopause Care With Telehealth Psychiatry: What the Report Says

Longevity.Technology reported on October 14, 2026 that Better U, a telehealth mental wellness provider, and Evernow, a menopause care company available to women in all 50 states, have formed a partnership that pairs menopause specialists with psychiatry in a nationwide telehealth service ^[1]. The stated aim is to treat the physical and emotional sides of perimenopause and menopause as one connected experience ^[1]. The article, by Kyle Umipig, draws on a company press release and notes that the release shares no outcome data ^[1].

What each side contributes

According to the report, Evernow contributes menopause and hormone therapy expertise, while Better U supplies integrative psychiatry, therapy and whole-body wellness services by telehealth ^[1]. Better U's wider offering also includes peptide and longevity therapies and GLP-1 weight management ^[1]. The clinical leads are Dr Ellamarie Russo-DeMara, Evernow's medical director, a board-certified OB/GYN with more than 30 years of clinical experience and a Menopause Society Certified Practitioner since 2009, and Dr Janette Leal, a board-certified psychiatrist trained in internal medicine and psychiatry with a geriatric psychiatry fellowship at Mayo Clinic ^[1].

Leal's rationale, as reported, is biological: she describes estrogen as helping regulate serotonin and dopamine, and allopregnanolone, a by-product of progesterone, as acting on the calming GABA receptors that help with sleep ^[1]. On her account, hormonal swings in perimenopause can present as new anxiety, broken sleep and brain fog, symptoms she says many women were told were due to stress or getting older ^[1]. These are a clinician's explanations quoted in a news article, not findings from a study described in the piece ^[1].

Why it matters for care teams

The report describes two separate organizations, one focused on hormonal care and one on psychiatry, presenting a joint service in which mood and menopausal symptoms are considered together ^[1]. The framing echoes a Longevity.Technology podcast episode the previous month, in which neurologist Dr David Dodick and gynecologist Dr Elizabeth Poynor made the case for seeing menopause as far more than a reproductive event ^[1]. In that episode, Dodick described menopause and perimenopause as a neurological and cardiometabolic transition as well as a reproductive and hormonal one ^[1]. The article points out that the new partnership addresses mood, sleep and brain fog but does not mention the metabolic and cardiovascular dimensions raised on the podcast ^[1]. The podcast guests also cautioned that evidence on the timing of hormone therapy is not definitive and argued for looking beyond a single hormone reading ^[1].

The ketamine component

The element the article singles out for a careful read is access to Better U's at-home ketamine therapy for women in perimenopause or menopause whose depression or anxiety has not improved with other treatments ^[1]. Each patient is screened by a licensed psychiatric clinician, and where clinically appropriate ketamine is prescribed off-label, meaning for a use beyond its formally approved ones, together with integration coaching and ongoing support ^[1]. The press release itself states that ketamine therapy "does not treat menopause itself and is not right for everyone" ^[1]. Given the absence of outcome data, the article characterizes the partnership as a new access model rather than a proven one ^[1].

What to watch

Better U says it intends to use advanced hormone monitoring to shift care from reactive treatment toward proactive monitoring and prevention, and the article notes it will be worth seeing what that looks like in practice ^[1]. Whether the service will release outcome data, on mental health symptoms generally or on the at-home ketamine pathway specifically, is not addressed in the announcement as reported ^[1]. The report also does not describe how patients move between the two organizations ^[1]. The article concludes that whether a telehealth partnership of this kind can make a measurable difference remains an open question that the announcement does not answer ^[1].